Russell Broadbent and a group comprising scientists, health professionals, lawyers, and academics, wrote to the Prime ...

Clinical-stage biotechnology company Vaxxas has appointed three global vaccine experts as advisors as it progresses its ...

Health-care companies rose after strong earnings from one major drug maker. Novo Nordisk shares rose sharply after the Danish obesity-drug maker posted fourth-quarter Ozempic sales of $4.71 billion, ...

Pfizer reported strong 2024 profits Wednesday on the same day the Connecticut Attorney General’s office released a statement ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

The leader of the French Patriots party, Florian Philippot, sharply criticized the statement of the head of the European ...

4Q Earnings: $410 million (loss of $3.4 billion 4Q24) ...

Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...

Dividend stocks are increasingly appealing for investors in 2025 due to their potential for steady income and resilience in ...

Pfizer reported better-than-expected quarterly profits on Tuesday behind cost cuts and growth in some non-Covid-related products including the blood clot drug Eliquis. Other pharmaceuticals with ...

The man behind SoftBank has now teamed up with OpenAI to invest up to $500 billion in American AI infrastructure over the next four years.